Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v4-FR | Version v3-EN | |
|---|---|---|
| Language | French | English |
| Date Updated | 2023-07-11 | 2023-07-11 |
| Drug Identification Number | 02416603 | 02416603 |
| Brand name | GALANTAMINE ER | GALANTAMINE ER |
| Common or Proper name | GALANTAMINE ER | GALANTAMINE ER |
| Company Name | PRO DOC LIMITEE | PRO DOC LIMITEE |
| Ingredients | GALANTAMINE | GALANTAMINE |
| Strength(s) | 24MG | 24MG |
| Dosage form(s) | CAPSULE (EXTENDED RELEASE) | CAPSULE (EXTENDED RELEASE) |
| Route of administration | ORAL | ORAL |
| Packaging size | 30 | 30 |
| ATC code | N06DA | N06DA |
| ATC description | ANTI-DEMENTIA DRUGS | ANTI-DEMENTIA DRUGS |
| Reason for shortage | Other (Please describe in comments) | Other (Please describe in comments) |
| Anticipated start date | ||
| Actual start date | 2019-06-20 | 2019-06-20 |
| Estimated end date | Unknown | Unknown |
| Actual end date | 2023-07-10 | 2023-07-10 |
| Shortage status | Resolved | Resolved |
| Tier 3 Status | No | No |
| Company comments | Discontinued as of July 10, 2023 – Discontinué en date du 10 juillet 2023. | Discontinued as of July 10, 2023 – Discontinué en date du 10 juillet 2023. |
| Health Canada comments |